Thrombocytopenia Among Patients with Hematologic Malignancies and Solid Tumors: Risk and Prognosis

被引：4
|
作者：
Adelborg, Kasper [1 ,2 ]
Veres, Katalin [1 ]
Horvath-Puho, Erzsebet [3 ]
Clouser, Mary [4 ]
Saad, Hossam A. [4 ]
Sorensen, Henrik Toft [5 ]
机构：
[1] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark
[3] Aarhus Univ, Dept Clin Epidemiol, Aarhus, Denmark
[4] Amgen Inc, Thousand Oaks, CA USA
[5] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, Aarhus, Denmark
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149668
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3156
引用
收藏
页数：5
相关论文
共 50 条
  • [1] The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies
    Shaw, Jaime L.
    Nielson, Carrie M.
    Park, Joseph K.
    Marongiu, Andrea
    Soff, Gerald A.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (05) : 662 - 672
  • [2] Perceptions of Prognosis Among Patients with Advanced Hematologic Malignancies
    Odejide, Oreofe O.
    Huntington, Scott F.
    Kuczmarski, Thomas M.
    Shi, Eleanor
    Tulsky, James A.
    Abel, Gregory A.
    BLOOD, 2021, 138
  • [3] Evaluation of the factors affecting the prognosis of patients with solid tumors and hematologic malignancies in the intensive care unit
    Savran Y.
    Arikan R.
    Comert B.
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [4] Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden
    Chang, Cindy M.
    Landgren, Ola
    Koshiol, Jill
    Bjoerkholm, Magnus
    Loeve, Thorvardur J.
    Kristinsson, Sigurdur Y.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (09) : 2208 - 2209
  • [5] A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies
    Al-Samkari, Hanny
    Parnes, Aric D.
    Goodarzi, Katayoon
    Weitzman, James I.
    Connors, Jean M.
    Kuter, David J.
    HAEMATOLOGICA, 2021, 106 (04) : 1148 - 1157
  • [6] Entinostat for treatment of solid tumors and hematologic malignancies
    Knipstein, Jeffrey
    Gore, Lia
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1455 - 1467
  • [7] Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors
    Lin, Swan
    Shaik, Naveed
    Martinelli, Giovanni
    Wagner, Andrew J.
    Cortes, Jorge
    Ruiz-Garcia, Ana
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (05): : 605 - 616
  • [8] Concurrent Tumors in Patients with Hematologic Malignancies
    Sumoza, Luis David
    Messinger, Marina
    Sumoza, Patricia
    Aguirre, Roxana
    Harsha, Poola
    Avila, Dayra
    BLOOD, 2014, 124 (21)
  • [9] Alisertib: a review of pharmacokinetics, efficacy and toxicity in patients with hematologic malignancies and solid tumors
    Liewer, Susanne
    Huddleston, Ashley
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (01) : 105 - 112
  • [10] CROSSING THE BRIDGE FROM HEMATOLOGIC MALIGNANCIES TO SOLID TUMORS
    APPELBAUM, FR
    THOMAS, ED
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (01) : 2 - 3
12345